Cho SI, Koketsu M, Fukazawa H, Ishihara H, Matsushita M, Nairn AC, Uehara Y (2000)
Novel compounds, ‘1,3-selenazine derivatives’ as specific inhibitors of eukaryotic elongation factor 2-kinase (calmodulin-dependent protein kinase-III).
Biochim Biophys Acta 1475: 207-215.
Nejime T, Kinjoh K, Nakamura M, Hanashiro K, Sunagawa M, Eguchi Y, Kosugi T (2000) Habutobin recognizes Tlr7 in the sequence of fibrinopeptide A of rabbit fibrinogen.
Toxicon 38: 1029-1041.
Li Q-B, Yu Q-S, Huang G-W, Tokeshi Y, Nakamura M, Kinjoh K, Kosugi T (2000) Hemostatic disturbances observed in patients with snakebite in south China.
Toxicon 38: 1355-1366.
Nakamura M, Sunagawa M, Kosugi T, and Sperelakis N (2000) Actin filament disruption inhibits L-type Ca2+ channel current in cultured vascular smooth muscle cells.
Am J Physiol 279: C480-C487.
Huang G-W, Sunagawa M, Li J-E, Shimada S, Zeng G, Tokeshi Y, Kosugi T (2000) The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma.
Laryngoscope 110: 2066-2069.
Sunagawa M, Kosugi T, Nakamura M and Sperelakis N (2000) Pharmacological actions of calmidazolium, a calmodulin antagonist, in cardiovascular system.
Cardiovascular Drug Reviews 18: 211-221.
Sperelakis N, Sunagawa M, Yokoshiki H, Seki T, Nakamura M (2000) Regulation of ion channels in myocardial cells and protection of ischemic myocardium.
Heart Fail Rev 5:139-166.
Yokoshiki H, Seki T, Sunagawa M, Sperelakis N (2000) Inhibition of Ca2+-activated K+ channels by tyrosine phosphatase inhibitors in rat mesenteric artery.
Can J Physiol Pharmacol 78: 745-750.
琉大医学部コンテンツ
